Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Clémence Lacroix"'
Autor:
Clémence Lacroix, Isabelle Alleman-Brimault, Arnaud Zalta, Frank Rouby, Catherine Cassé-Perrot, Elisabeth Jouve, Laurence Attolini, Romain Guilhaumou, Joëlle Micallef, Olivier Blin
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Medical use of cannabis has been receiving growing attention over the last few decades in modern medicine. As we know that the endocannabinoid system is largely involved in neurological disorders, we focused on the scientific rationale of medical can
Externí odkaz:
https://doaj.org/article/96c809222cca4072b1cc51e970df6c3b
Publikováno v:
Frontiers in Psychiatry, Vol 12 (2021)
Opioid analgesics and maintenance treatments, benzodiazepines and z-drugs, and other sedatives and stimulants are increasingly being abused to induce psychoactive effects or alter the effects of other drugs, eventually leading to dependence. Awarenes
Externí odkaz:
https://doaj.org/article/9621defb12e84b4db5d83a3a48e80a54
Autor:
Clémence Lacroix, Annie-Pierre Bera-Jonville, François Montastruc, Lionel Velly, Joëlle Micallef, Romain Guilhaumou
Publikováno v:
Antibiotics, Vol 10, Iss 5, p 540 (2021)
We described ceftriaxone-induced CNS adverse events through the largest case series of Adverse Drug Reactions (ADRs) reports, from 1995 to 2017, using the French Pharmacovigilance Database. In total, 152 cases of serious CNS ADRs were analyzed; 112 p
Externí odkaz:
https://doaj.org/article/64ef58b9bd244d3a98cd0275badc02d2
Autor:
Flora Marchandise, Coralie Lo Presti, Matthieu Peretti, Oriane De Mauroy, Clémence Lacroix, Camille Heyries, Anthony Loru, Elodie Bambina, Virginie Aghazarian, Stéphanie Guise-Honoré
Publikováno v:
Le Pharmacien Clinicien. 58:59-64
Autor:
Clémence Guerra, Thomas Soeiro, Clémence Lacroix, Elisabeth Jouve, Joelle Micallef, Elisabeth Frauger
Publikováno v:
Therapies. 77:713-721
Publikováno v:
Therapies.
Autor:
Clémence Lacroix, Robinson Gravier Dumonceau, Joëlle Micallef, Adeline Giocanti, Thomas Soeiro, Salim Mezaache, Elisabeth Frauger
Publikováno v:
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, Wiley, 2022, 36 (2), pp.436-442. ⟨10.1111/fcp.12738⟩
Fundamental & Clinical Pharmacology, Wiley, 2022, 36 (2), pp.436-442. ⟨10.1111/fcp.12738⟩
BACKGROUND Accumulating evidence shows that some antidepressants are abused for their psychostimulant effects, but the extent of antidepressants abuse is unknown in subjects with opioid use disorders (OUD). OBJECTIVES To assess the prevalence of anti
Autor:
Emmanuel Oger, Sylvie Picard, et le réseau français des Centres régionaux de pharmacovigilance, Lucie-Marie Scailteux, Elisabeth Polard, Sandrine Bergeron, Clémence Lacroix, Fabien Despas, Marion Sassier, Louise Triquet
Publikováno v:
Therapies
Therapies, 2021, 76 (5), pp.455-465. ⟨10.1016/j.therap.2020.12.012⟩
Therapies, 2021, 76 (5), pp.455-465. ⟨10.1016/j.therap.2020.12.012⟩
Resume Objectif L’objectif de cette etude etait de decrire le profil d’effets indesirables de l’abiraterone et l’enzalutamide, a partir des cas enregistres par les centres regionaux de pharmacovigilance francais pour identifier de potentiels
Autor:
Clémence Lacroix, Anaïs Maurier, Bérenger Largeau, Alexandre Destere, Eve-Marie Thillard, Milou Drici, Joëlle Micallef, Annie Pierre Jonville-Bera
Publikováno v:
Therapie.
Pharmacovigilance and pharmacoepidemiology studies regarding the sex difference in adverse drug reactions are numerous, and it is now a challenge to take them into account in order to increase drug safety. Here, we present an overview of this topic t
Autor:
Clémence Lacroix, Sébastien Caudron De Coquereaumont, Liselotte Pochard, Elisabeth Frauger, Joëlle Micallef
Publikováno v:
Therapies. 77:768-769